Item request has been placed!
×
Item request cannot be made.
×
Processing Request
OncoSec Medical Inc.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): NEILSSIEN, TRACY
- Source:
START -- UP. Feb2013, Vol. 18 Issue 2, p30-32. 3p.
- Subject Terms:
- Additional Information
- Subject Terms:
- Subject Terms:
- Abstract:
The article profiles OncoSec Medical Inc. in San Diego, California and provides information on its ImmunoPulse, an electroporation-based gene and drug delivery technology for the treatment of metastatic melanoma and other forms of rare skin cancers. Details on the founders, investors, board of directors and financing of the company are cited. It offers information on the Phase II clinical trial designed to test the safety and efficacy of ImmunoPulse in metastatic melanoma patients.
No Comments.